Jenoptik: rise in first-quarter order figures provides sound basis for further development

In the first three months of 2019, order intake was up 5.6 percent to 210.4 million euros, order backlog rose from 27.4 million euros to 548.9 million euros  Group generated revenue of 184.0 million euros (prior year: 189.9 million euros) In line with expectations, EBITDA came to 23.8 million euros, down on prior-year 27.7 million … „Jenoptik: rise in first-quarter order figures provides sound basis for further development“ weiterlesen

Change in Leadership on the executive Board Of Knorr-Bremse AG

Klaus Deller leaves the company after ten years by mutual agreement Supervisory Board initiates the search for his successor Members of the Executive Board will assume the responsibilities in the interim Klaus Deller, the Chairman of the Executive Board of Knorr-Bremse AG, will leave the company on April 30 by mutual agreement. The Supervisory Board … „Change in Leadership on the executive Board Of Knorr-Bremse AG“ weiterlesen

„Beste Berater 2019“ Die Management Angels wurden zum sechsten Mal in Folge ausgezeichnet!

Die jährliche Branchenstudie von brand eins und Statista zeichnet die Management Angels GmbH auch 2019 wieder als Top-Berater in Deutschland aus

Die jährliche Branchenstudie von brand eins und Statista zeichnet die Management Angels GmbH auch 2019 wieder als Top-Berater in Deutschland aus

MorphoSys gibt Update zu klinischen Studien L-MIND und B-MIND mit Wirkstoff MOR208 bei rezidivierendem oder refraktärem DLBCL bekannt

Die MorphoSys AG (Frankfurt: MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ: MOR) gab heute Neuigkeiten zu den beiden laufenden klinischen Studien L-MIND und B-MIND mit seinem Fc-wirkverstärkten, gegen CD19 gerichteten Antikörper MOR208 bekannt. In den Studien wird MOR208 bei Patienten mit rezidivierendem oder refraktärem diffusem großzelligem B-Zell-Lymphom (r/r DLBCL) erprobt, die nicht für eine … „MorphoSys gibt Update zu klinischen Studien L-MIND und B-MIND mit Wirkstoff MOR208 bei rezidivierendem oder refraktärem DLBCL bekannt“ weiterlesen

Wachstumsstrategie und veränderte Unternehmensstruktur in 2019

Management Angels GmbH beendet Franchisemodell und begleitet Ausgründung der Franchisetochter

Management Angels GmbH beendet Franchisemodell und begleitet Ausgründung der Franchisetochter

Ravenquest’s George Robinson appointed acting President & CEO of Bonify

RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB, OTCQB: RVVQF, Frankfurt: 1IT) announces George Robinson, CEO, has been named interim President & CEO of Bonify Medical Cannabis (BMC), Ltd. (“Bonify”). Bonify Chairman, Jeffery Dyck, stated that “George Robinson’s knowledge and experience is superb when it comes to cannabis production pursuant to Health Canada … „Ravenquest’s George Robinson appointed acting President & CEO of Bonify“ weiterlesen

Transaction volume in 9M/18 increased by 44.2 percent

Consolidated revenues increased by 41.4 percent / EBITDA increased by 38.0 percent / Free cash flow increased by 42.0 percent / EBITDA 2018 guidance raised

Consolidated revenues increased by 41.4 percent / EBITDA increased by 38.0 percent / Free cash flow increased by 42.0 percent / EBITDA 2018 guidance raised

Sales grow despite difficult market conditions, margin decrease

Revenue grows 5.1 percent at constant currency in the first nine months EBIT margin before special items for the same period at 10.7 percent (prior year: 11.4 percent) Performance declines in both Automotive divisions, Industrial division business remains strong Free cash flow before in- and outflows for M&A activities of 127 million euros below prior … „Sales grow despite difficult market conditions, margin decrease“ weiterlesen

DEUTZ AG: Saarbrücken Regional Court orders Neue Halberg Guss GmbH to resume supply to DEUTZ AG immediately

Resounding success for DEUTZ in injunction proceedings Dr Frank Hiller, Chairman of the Board of Management: "The madness has come to an end." Planning certainty for employees and customers of DEUTZ AG. At the request of DEUTZ AG, the Saarbrücken Regional Court today ruled that Neue Halberg Guss GmbH (NHG) must resume supplying cast parts … „DEUTZ AG: Saarbrücken Regional Court orders Neue Halberg Guss GmbH to resume supply to DEUTZ AG immediately“ weiterlesen